Cafepharma Today

June 4 2025 - Moderna will test new COVID shot against placebo, Robert F Kennedy Jr. says
Moderna will test new COVID shot against placebo, Robert F Kennedy Jr. says
Massachusetts’ life sciences job growth flattens after 10+ years of increases
CDC official overseeing COVID-19 vaccine recommendations resigns
Lilly inks deal worth up to $870M to develop long-acting GLP-1 obesity drugs
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Allergan poison pill presages a battle against Valeant's $47B takeover
Fierce Pharma
Wednesday, April 23, 2014 - 12:48pm
tags:
poison pill, Valeant Pharmaceuticals, M&A
Say Hello to the New Fastest Growing Drug in History!
Motley Fool
Wednesday, April 23, 2014 - 12:36pm
tags:
Gilead Sciences, Sovaldi, hepatitis C, drug launches
NICE rejects Roche's hot new breast cancer drug Kadcyla, then invites negotiations
Fierce Pharma
Wednesday, April 23, 2014 - 12:02pm
tags:
breast cancer, Roche, NICE, Kadcyla, HER2-positive metastatic breast cancer
Companies Betting on the Next 10 Blockbuster Drugs
24/7WallStreet
Wednesday, April 23, 2014 - 11:57am
tags:
Juxtapid, Otezla, Aegerion, Celgene, GW Pharma, Sativex, Intercept Pharma, OCA, Ironwood Pharmaceuticals, Linzess, Lpath, iSONEP, MannKind, Afrezza, Xtandi, H.P. Acthar Gel, Questcor Pharmaceuticals, eteplirsen, Sarepta Therapeutics
Should Amgen Break Itself Up?
Forbes
Wednesday, April 23, 2014 - 10:56am
tags:
Amgen
Today's Health Care Stocks to Watch: Illumina Inc., Intuitive Surgical Inc. and Gilead Sciences
Motley Fool
Wednesday, April 23, 2014 - 10:41am
tags:
Illumina, Intuitive Surgical, earnings, devices, Gilead Sciences
Why Valeant International Inc. Is Acquiring Botox and Juvederm Maker Allergan
Motley Fool
Wednesday, April 23, 2014 - 10:34am
tags:
Valeant Pharmaceuticals, Allergan, M&A, medical aesthetics
Alnylam Strikes Back: Comments From CEO John Maraganore
Forbes
Wednesday, April 23, 2014 - 10:19am
tags:
Pharma CEOs, John Maraganore, Alnylam, RNAi
Gilead: X-Marks The Spot For Sovaldi Sales
Seeking Alpha
Wednesday, April 23, 2014 - 10:18am
tags:
Gilead Sciences, Sovaldi, hepatitis C, Incyte, Clovis Oncology, Puma Biotechnology
Earnings Roundup: Baxter International Grows Ahead of Its Spin-Off
Motley Fool
Wednesday, April 23, 2014 - 9:46am
tags:
Baxter International, earnings
Why Ironwood Pharmaceuticals (IRWD) is Poised to Beat Earnings Estimates (Again)
Yahoo/Zacks.com
Wednesday, April 23, 2014 - 9:18am
tags:
earnings, Ironwood Pharmaceuticals
Spectrum Pharma's cancer drug meets main goal in trial
Yahoo/Reuters
Wednesday, April 23, 2014 - 8:44am
tags:
Spectrum Pharmaceuticals, melphalan, Multiple Myeloma
The Novartis-Glaxo-Lilly Swap’s Downside: Less Research
Bloomberg/Businessweek
Wednesday, April 23, 2014 - 8:42am
tags:
Novartis, Eli Lilly, R&D, GSK, M&A
Novartis, Valeant bids herald new deal-making era for pharma
Yahoo/Reuters
Wednesday, April 23, 2014 - 8:30am
tags:
Novartis, Valeant Pharmaceuticals, GSK, Eli Lilly, M&A, Allergan
Biogen Profit Increases on Multiple Sclerosis Drug Sales
Bloomberg
Wednesday, April 23, 2014 - 8:28am
tags:
earnings, Biogen Idec
Amgen Falls as Earnings, Revenue Disappoint
Barron's
Tuesday, April 22, 2014 - 4:55pm
tags:
Amgen, earnings
Gilead profit triples, hepatitis C drug revenue reaches $2.3 bln
Yahoo/Reuters
Tuesday, April 22, 2014 - 4:54pm
tags:
Gilead Sciences, earnings
Is This a Good Deal for Novartis AG and GlaxoSmithKline plc?
Motley Fool
Tuesday, April 22, 2014 - 4:20pm
tags:
Novartis, GSK, M&A
Earnings Preview: Amgen's timeline for Evolocumab will be in focus
The Fly on the Wall
Tuesday, April 22, 2014 - 3:33pm
tags:
earnings, Amgen, evolocumab
FDA advisers unanimously reject experimental pain pill combining morphine and oxycodone
Yahoo/AP
Tuesday, April 22, 2014 - 3:30pm
tags:
FDA, advisory panels, painkillers, MoxDuo, QRxPharma

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.